PMID- 19421174 OWN - NLM STAT- MEDLINE DCOM- 20100323 LR - 20171116 IS - 1476-5365 (Electronic) IS - 0268-3369 (Linking) VI - 45 IP - 1 DP - 2010 Jan TI - Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis. PG - 181-9 LID - 10.1038/bmt.2009.89 [doi] AB - Enrichment of cell subpopulations is a prerequisite for lineage-specific chimerism analysis (LCA), a frequent approach in follow-up after allo-SCT. An efficient enrichment technique is Magnetic Cell Sorting (MACS) using the AutoMACS separator. However, evaluation of purity, recovery and applicability for PCR-based chimerism analysis of MACS-enriched subpopulations from post-transplant peripheral blood, providing reduced cell numbers and/or unbalanced proportions of subpopulations, is currently unavailable. We performed enrichment of CD3-, CD14-, CD15-, CD19- and CD56-positive subpopulations using 'Whole Blood MicroBeads' and AutoMACS separator in 137 prospectively collected peripheral blood samples from 15 paediatric patients after allo-CD3-/CD19-depleted SCT. Purity was assessed by immune phenotyping. Recovery and applicability for chimerism analysis was evaluated. Excellent purity >90% was achieved in CD14-, CD15-positive cells in 81%, 95% of the isolates and in 86% of CD3 and CD19 isolates, if ACC was >400 cells per mul. Median purity of CD56-positive isolates was 78.9%. Recovery >90% was between 93 (CD56) and 37% (CD15). Conventional and real-time PCR-based chimerism analysis was feasible in virtually all samples. Isolation of cell subpopulations by automated cell enrichment in post-transplant peripheral blood is feasible and fast providing excellent purity and recovery for routine lineage-specific chimerism analysis. FAU - Willasch, A AU - Willasch A AD - Department of Pediatric Hematology, Oncology and Hemostaseology, Goethe University Frankfurt, Hospital for Children and Adolescents III, Frankfurt, Germany. andre.willasch@kgu.de FAU - Eing, S AU - Eing S FAU - Weber, G AU - Weber G FAU - Kuci, S AU - Kuci S FAU - Schneider, G AU - Schneider G FAU - Soerensen, J AU - Soerensen J FAU - Jarisch, A AU - Jarisch A FAU - Rettinger, E AU - Rettinger E FAU - Koehl, U AU - Koehl U FAU - Klingebiel, T AU - Klingebiel T FAU - Kreyenberg, H AU - Kreyenberg H FAU - Bader, P AU - Bader P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090504 PL - England TA - Bone Marrow Transplant JT - Bone marrow transplantation JID - 8702459 RN - 0 (Antigens, CD19) RN - 0 (CD3 Complex) RN - 0 (CD56 Antigen) RN - 0 (Lewis X Antigen) RN - 0 (Lipopolysaccharide Receptors) SB - IM MH - Adolescent MH - Adult MH - Antigens, CD19/immunology MH - CD3 Complex/immunology MH - CD56 Antigen/immunology MH - *Cell Lineage MH - Cell Separation/*methods MH - Child MH - Child, Preschool MH - Female MH - Flow Cytometry/methods MH - Hematopoietic Stem Cell Transplantation/*methods MH - Humans MH - Lewis X Antigen/immunology MH - Lipopolysaccharide Receptors/immunology MH - Lymphocyte Subsets/*immunology MH - Magnetics MH - Male MH - Polymerase Chain Reaction MH - Polymorphism, Genetic MH - Postoperative Care MH - Tandem Repeat Sequences MH - Transplantation Chimera/*immunology EDAT- 2009/05/08 09:00 MHDA- 2010/03/24 06:00 CRDT- 2009/05/08 09:00 PHST- 2009/05/08 09:00 [entrez] PHST- 2009/05/08 09:00 [pubmed] PHST- 2010/03/24 06:00 [medline] AID - bmt200989 [pii] AID - 10.1038/bmt.2009.89 [doi] PST - ppublish SO - Bone Marrow Transplant. 2010 Jan;45(1):181-9. doi: 10.1038/bmt.2009.89. Epub 2009 May 4.